Data from Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib

MLA

Lori J. Wirth, et al. Data from Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6524388.

APA

Lori J. Wirth, Gilbert H. Daniels, Edwin L. Palmer, David G. McFadden, & S. Michael Rothenberg. (2023). Data from Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib. https://doi.org/10.1158/1078-0432.c.6524388

Chicago

Lori J. Wirth, Gilbert H. Daniels, Edwin L. Palmer, David G. McFadden, and S. Michael Rothenberg. 2023. “Data from Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib,” March. doi:10.1158/1078-0432.c.6524388.